In breast cancer, the glycans recognized by MAL-I, ECA, NPA, BPL, BS-I, PTL-II, DBA, PNA, PHA-E + L, UEA-I, and PWM showed differential expression.41 In gastric cancer, the glycans recognized by ECA, PSA, PHA-E + L, HHL, PNA, EEL, MPL, and GSL-I showed differential expression.31 In hepatic carcinoma, the glycans recognized by MAL-II, SNA, WFA, PNA, and AAL showed differential expression.42 In lung cancer, the alteration in the glycopattern is different from breast cancer, gastric cancer and hepatic carcinoma. Here, RPS19 is linked to hepatocellular carcinoma.